Capital Cell
Funding platformBarcelona · Pre-Seed–Growth
Investment thesis
Capital Cell operates an equity crowdfunding-style investment platform dedicated to biotechnology and life sciences. It curates opportunities through the BioExpert Network, an independent community of more than 3,500 experts in life sciences, health, biotech, and medicine, admitting only about 3% of companies that apply. Each selected company is chosen for its potential to scale globally and deliver strong returns, allowing investors to co-invest alongside leading scientific, investment, and social-impact institutions while making an impact on the future of global health.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 35 of 67 portfolio companiesMedical Devices ×22Healthtech ×21Biotech ×20Digital Health ×9Deep Tech ×6AI & Machine Learning ×5Wellness & Fitness ×4Hardware ×3
HQs:Spain×11Switzerland×1United Kingdom×1United States×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×52 founders×53 founders×34+ founders×1
Investments · 67 tracked
founders shown can be your intro pathAbilityPharma is a biopharmaceutical company developing first-in-class drug candidates for cancer, using autophagy as a therapeutic strategy to selectively induce cell death in cancer cells.
BiotechHealthtech
Co-investorsCTI Life Sciences Fund L.P.
Airway Shield develops a patented protective device used during endotracheal intubation to reduce dental trauma, patient complications, and infection risk to clinicians.
HardwareHealthtechMedical Devices
AntalGenics is a biotechnology company that discovers and develops active molecules for biomedical and dermocosmetic applications, focusing on sensory neurobiology, peripheral mechanisms, and topical treatments.
BiotechDeep TechWellness & FitnessElche, ES
Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease.
BiotechHealthtechMedical DevicesBadalona, ES
Antoni Matilla Dueñas(CEO & Co-Founder)Ivelisse Sánchez(CSO & Co-Founder)Jaime Melendo(Board Member & Co-Founder)Daniel Pérez(Chief Financial Officer)
Bionure develops next-generation therapies using therapeutic RNA, chemical compounds, peptidomimetics, and oligonucleotides to treat rare neurodegenerative and neuro-inflammatory diseases such as ALS, Rett syndrome, ataxia, and Huntington's disease.
BiotechDeep TechHealthtech
Carmen Sanfrancisco(CEO (Consejera Delegada), Bionure Investment)Pere Monràs(President (Presidente), Bionure Investment)
Corify develops ACORYS, a cardiac mapping system for clinicians that performs real-time, beat-to-beat global cardiac mapping to help diagnose cardiac arrhythmias.
HealthtechMedical Devices
Cuideo is a platform that connects families with screened home care professionals for elderly and dependent relatives in Spain.
B2B MarketplacesHealthtechBarcelona, ES
Co-investorsDozen InvestmentsInderhabsMundi Ventures
Dermavision Solutions builds Deviskan, an automated device that combines total body mapping and digital dermoscopy to capture full-body clinical images and support dermatologists in patient monitoring and early melanoma detection.
Digital HealthHealthtechMedical Devices
EnricNarcís
Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.
ConsumerHealthtechWellness & Fitness
Co-investorsCriteria Bio VenturesEmesa Corporación EmpresarialShip2B
ELEM builds healthcare digital twins and virtual human populations that simulate drug and device performance across diverse patient groups, letting pharmaceutical companies, CROs, regulators, and clinicians generate in silico clinical evidence before real trials.
AI & Machine LearningBiotechDigital Health
Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite.
BiotechLongevityMedical Devices
Giacomo de Simone(CEO)David M. Selva(CSO)Rafael Simó(CMO)Agustí Soler(CFO)
EVerZom is a biotech company developing exosome-based (extracellular vesicle) therapeutics for regenerative medicine, with an innovation platform covering cell sourcing, exosome generation, loading, and formulation.
BiotechDeep TechMedical Devices
Fecundis is a biotechnology company developing sperm-centered technologies for assisted reproduction, including HyperSperm, a sequential-step kit that recreates physiological sperm capacitation in vitro for IVF and ICSI.
BiotechFemTechHealthtech
Mariano Buffone(Co-founder & CSO)inDario Krapf(Co-founder & CSO)inArina Rogozina(CEO)inMatías Gómez Elías(COO)in
Co-investorsGRIDX
mjn develops neurological monitoring technology solutions for patients with epilepsy and other neurological disorders.
AI & Machine LearningHealthtechMedical Devices
Co-investorsShip2B
MOWOOT is a non-invasive medical device that delivers Intermittent Colonic Exoperistalsis (ICE), applying gentle sequential abdominal pressure inspired by clinical abdominal massage to support bowel movement in people with chronic constipation.
Digital HealthHealthtechMedical Devices
Immaculada Herrero Fresneda, PhD.(Founder)in
Co-investorsMonte Carlo CapitalShip2B
Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications.
BiotechDeep TechMedical Devices
Samuel Sánchez
Co-investorsBStartup
Nexkin Medical develops technology and digital tools for allergy testing to support understanding, diagnosis, treatment, and follow-up of allergies.
Digital HealthHealthtechMedical Devices
Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring.
Digital HealthHardwareMedical Devices
Co-investorsCriteria Bio VenturesFides Capital
Oncostellae is a clinical-stage biopharmaceutical company that discovers and develops proprietary drug candidates for unmet medical needs in immunology and oncology, advancing them from concept through Phase I/II before licensing further development and commercialization to larger pharmaceutical companies.
BiotechHealthtech
Open Stent Solution develops the Cornelis Valve, a transcatheter device for percutaneous replacement of the mitral and tricuspid heart valves, based on a valved-ribbon design.
BiotechHealthtechMedical Devices
Ownmed Innovation is a spin-off that develops medical devices and technologies to address unmet clinical needs, taking products through preclinical studies, clinical trials, and CE certification under EU regulation 2017/745.
BiotechHealthtechMedical Devices
OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients.
HardwareHealthtechMedical Devices
Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds.
AI & Machine LearningBiotechDeep TechBarcelona, ES
Enric Gibert(Founder)Enric Herrero(Founder)
Co-investorsGENERAL INCEPTIONHeran Partners
StimuSIL is a medical device company developing subdermal photobiomodulation technology that uses patented methods to deliver light-based stimulation beneath the skin's melanin layer for dermatology and aesthetics indications.
BiotechHealthtechMedical DevicesWellness & FitnessWilmington, US
Ana Isabel Villalba Villar(Founder)inAna Villalba Villar(Executive Officer, Director)Pablo Villalba(Executive Officer, Director)Firat Yerlikaya(Director)
BoardAbidin Gulmus(Director)
The Sampling Solutions (TSS) plans, executes, and digitizes water sampling, inspections, and audits across Spain using a network of ISO 17025-qualified field technicians.
CleantechClimate TechSaaS
Time is Brain develops BraiN20®, a real-time brain monitoring device for stroke patients that provides bedside neurological data to guide treatment decisions during time-critical interventions.
Deep TechHealthtechMedical DevicesBarcelona, ES
Dr. Alicia Martínez(Co-founder)Dr. Antoni Dávalos(Co-founder)Dr. Jaume Coll(Co-founder)
VERIGRAFT develops technology that modifies donated tissue so it resembles a patient's own tissue, aiming to eliminate immune rejection in transplantation and reduce the need for lifelong immunosuppressants.
BiotechHealthtechMedical Devices
Petter Björquist(PhD, Chief Executive Officer)
Co-investorsScientia Ventures
Vytrus Biotech develops natural active ingredients for skin and hair care cosmetics using plant stem cell biotechnology, producing them at industrial scale under controlled conditions.
BiotechConsumerWellness & Fitness
Portfolio news
latest coverage across their companiesPharmacelera · ddw-online.com · Feb 20, 2026
Frequently asked questions
- How many investments has Capital Cell made?
- Capital Cell has 67 tracked investments.
- What stage does Capital Cell invest at?
- Capital Cell invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Capital Cell focus on?
- Capital Cell focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Capital Cell located?
- Capital Cell is headquartered in Barcelona, ES.
- Who does Capital Cell co-invest with?
- Capital Cell most often shares deals with Ship2B, BStartup, Criteria Bio Ventures, among 15 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Accelmed Partners is a healthcare technology investment firm that applies a private equity approach to a sector traditionally served by venture and early-stage growth investors, focusing on tools & diagnostics, digital health, and tech-enabled services.






.jpeg)
